"The company said that its tool was "highly accurate" in a 425-participant study conducted across 14 U.S. sites...." Lire la suite
Cognoa targets De Novo authorization for its autism diagnostic after reporting strong pivotal study results
mobihealthnews, 23/09/2020
Partagé par :
Équipe Beesens